ABT-299 is a prodrug of a platelet-activating factor (PAF) antagonist that exhibits significant inhibitory activity on PAF-induced beta-platelet globulin release in vitro after in vivo administration in humans, an effect that may be partially attributed to the pyridine-N-oxide metabolite.
Molekulargewicht:
619.11
CAS Nummer:
[161395-35-3]
Formel:
C32H28ClFN4O4S
Target-Kategorie:
Platelet-activating Factor Receptor (PAFR)
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten